Skip to main content

Umbralisib Tosylate

(UM-brah-LIH-sib TOH-suh-layt)

This page contains brief information about umbralisib tosylate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Ukoniq
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Umbralisib tosylate is approved to treat:

These uses are approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that umbralisib tosylate provides a clinical benefit in these patients. Umbralisib tosylate is also being studied in the treatment of other types of cancer.

More About Umbralisib Tosylate

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Umbralisib Tosylate - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: